Yarboro Leora T, Bergin James D, Kennedy Jamie L W, Ballew Carole C, Benton Emily M, Ailawadi Gorav, Kern John A
1 Department of Surgery, 2 Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Ann Cardiothorac Surg. 2014 Nov;3(6):557-62. doi: 10.3978/j.issn.2225-319X.2014.09.08.
Left ventricular assist devices (LVADs) are increasingly utilized in the management of advanced heart failure. A transcutaneous driveline is necessary to power the LVAD, and although this technology has improved over the years in terms of smaller size and increased durability, driveline complications continue to develop in up to 20% of all devices implanted. Driveline infections are associated with significant morbidity and mortality. As more patients live longer with ventricular assist devices, minimizing driveline infections is paramount. A systematic, multidisciplinary approach can be used to develop a strategy to prevent, recognize and treat driveline infections. In this paper, we describe our approach to driveline management which has resulted in zero driveline infections between January 2012 and March 2014.
左心室辅助装置（LVADs）在晚期心力衰竭的治疗中应用越来越广泛。经皮驱动线是LVAD供电所必需的，尽管多年来这项技术在尺寸变小和耐用性增强方面有所改进，但高达20%的植入装置仍会出现驱动线并发症。驱动线感染与严重的发病率和死亡率相关。随着越来越多的患者使用心室辅助装置存活更长时间，将驱动线感染降至最低至关重要。可以采用系统的多学科方法来制定预防、识别和治疗驱动线感染的策略。在本文中，我们描述了我们的驱动线管理方法，该方法在2012年1月至2014年3月期间实现了零驱动线感染。
